Worldwide vaccine inequality threatens to unleash the next COVID-19 variant
Published by Elsevier Ltd..
The emergence of the Omicron variant (B.1.1.529 BA.1) near Johannesburg heralded the development of an unprecedented number of new COVID-19 infections across South Africa in November 2021. Omicron and its subvariants would soon become the dominant strains across Africa, Europe, and the United States. As with the Delta variant (B.1.617.2), Omicron emerged from an industrialized nation with one of the lowest vaccination rates of any well-developed country. The emergence of variants from undervaccinated regions is a direct consequence of the virus replicating unchecked through an unprotected population. Despite this, the United States and other higher-income nations have adopted a strategy of preferentially inoculating their citizens with multiple and booster doses, whereas lower-income nations struggle with vaccine availability, infrastructure, and their own vaccine manufacturing capability. Much more needs to be done to address worldwide vaccine inequities and prevent the emergence of the next devastating variant. The persistence of the pandemic anywhere remains an ongoing threat to citizens everywhere.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:123 |
---|---|
Enthalten in: |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 123(2022) vom: 18. Okt., Seite 133-135 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Oehler, Richard L [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 04.10.2022 Date Revised 17.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ijid.2022.08.010 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM345073991 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM345073991 | ||
003 | DE-627 | ||
005 | 20231226024239.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijid.2022.08.010 |2 doi | |
028 | 5 | 2 | |a pubmed24n1150.xml |
035 | |a (DE-627)NLM345073991 | ||
035 | |a (NLM)35988865 | ||
035 | |a (PII)S1201-9712(22)00480-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Oehler, Richard L |e verfasserin |4 aut | |
245 | 1 | 0 | |a Worldwide vaccine inequality threatens to unleash the next COVID-19 variant |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 04.10.2022 | ||
500 | |a Date Revised 17.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Published by Elsevier Ltd. | ||
520 | |a The emergence of the Omicron variant (B.1.1.529 BA.1) near Johannesburg heralded the development of an unprecedented number of new COVID-19 infections across South Africa in November 2021. Omicron and its subvariants would soon become the dominant strains across Africa, Europe, and the United States. As with the Delta variant (B.1.617.2), Omicron emerged from an industrialized nation with one of the lowest vaccination rates of any well-developed country. The emergence of variants from undervaccinated regions is a direct consequence of the virus replicating unchecked through an unprotected population. Despite this, the United States and other higher-income nations have adopted a strategy of preferentially inoculating their citizens with multiple and booster doses, whereas lower-income nations struggle with vaccine availability, infrastructure, and their own vaccine manufacturing capability. Much more needs to be done to address worldwide vaccine inequities and prevent the emergence of the next devastating variant. The persistence of the pandemic anywhere remains an ongoing threat to citizens everywhere | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Healthcare disparity | |
650 | 4 | |a Pandemic | |
650 | 4 | |a Vaccines | |
650 | 4 | |a Variants | |
650 | 7 | |a Vaccines |2 NLM | |
700 | 1 | |a Vega, Vivian R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases |d 1998 |g 123(2022) vom: 18. Okt., Seite 133-135 |w (DE-627)NLM094730857 |x 1878-3511 |7 nnns |
773 | 1 | 8 | |g volume:123 |g year:2022 |g day:18 |g month:10 |g pages:133-135 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijid.2022.08.010 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 123 |j 2022 |b 18 |c 10 |h 133-135 |